Purpose: The pharmacology, efficacy, and safety of etravirine and its clinical utility with respect to the available alternative human immunodeficiency virus (HIV) treatment options are reviewed.
HIV-1 reverse transcriptase inhibitors have long been central to antiretroviral therapy, effectively impeding the enzyme responsible for converting viral RNA into DNA – a pivotal step in HIV ...
† Drugs combined with NRTIs or NRTIs/NNRTIs are not listed. NNRTIs: Non-nucleoside reverse-transcriptase inhibitors; NRTIs: Nucleos(t)ide analog reverse-transcriptase inhibitors. Drug-resistance amino ...
After 48 weeks of treatment, TPN-101 reduced the levels of neurofilament light chain and interleukin 6, both key biomarkers of neurodegeneration and neuroinflammation in PSP. The Food and Drug ...
In late 2012, researchers showed how the cGAS-STING pathway detects pathogenic DNA to guard against viral and bacterial invaders. A decade on, Ventus Therapeutics is ready to test a first inhibitor of ...
Rome Therapeutics raises new funds to advance LINE-1 reverse transcriptase inhibitor into clinic Sep. 13, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback